Stock GHSI GUARDION HEALTH SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Guardion Health Sciences, Inc.

Equities

GHSI

US40145Q5009

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-06-05 pm EDT 		5-day change 1st Jan Change
10.04 USD +5.13% Intraday chart for Guardion Health Sciences, Inc. +11.04% +88.01%
May. 31 Doctor's Best, Inc. completed the acquisition of Activ Nutritional, LLC. from Guardion Health Sciences, Inc.. CI
May. 13 Guardion Health Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Guardion Health Sciences, Inc. is a clinical nutrition company. The Company offers a portfolio of science-based, clinically supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients. The Company sells two ocular products: GlaucoCetin and Lumega-Z. GlaucoCetin is a dietary supplement in a capsule form designed specifically to provide nutrients to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health. Lumega-Z, its medical food product, has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. As a medical food, Lumega-Z must be administered under the supervision of a physician or professional healthcare provider. It sells GlaucoCetin and Lumega-Z on its Website, guardionhealth.com.

Number of employees: 9

Sales per Business

USD in Million2022Weight2023Weight Delta
Nutritional Supplements
97.2 %
- - 12 97.2 % -
Ocular
2.8 %
- - 0 2.8 % -

Sales per region

USD in Million2022Weight2023Weight Delta
North America
100.0 %
11 99.8 % 12 100.0 % +11.04%

Managers

Managers TitleAgeSince
Jan Hall CEO
 Chief Executive Officer - 23-06-18
Robert Weingarten CHM
 Chairman 72 15-06-29
Katie Cox AUD
 Comptroller/Controller/Auditor - 23-07-24
Susan Klein PRN
 Corporate Officer/Principal - -
Craig Sheehan PRN
 Corporate Officer/Principal 53 21-06-02

Members of the board

Members of the board TitleAgeSince
Robert Weingarten CHM
 Chairman 72 15-06-29
Mark Goldstone BRD
 Director/Board Member 60 15-05-31
Donald Gagliano BRD
 Director/Board Member 71 19-04-08
Michaela Griggs BRD
 Director/Board Member - 21-12-08

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,284,156 1,023,659 ( 79.71 %) 0 79.71 %

Shareholders

NameEquities%Valuation
Bradley Radoff
18.92 %
243,000 18.92 % 2 M $
Renaissance Technologies LLC
2.945 %
37,820 2.945 % 308 233 $
Vanguard Group, Inc. (Subfiler)
1.157 %
14,852 1.157 % 121 044 $
BlackRock Institutional Trust Co. NA
0.7811 %
10,030 0.7811 % 81 745 $
Robert Weingarten
0.5354 %
6,875 0.5354 % 56 031 $
Bret Scholtes
0.4594 %
5,900 0.4594 % 48 085 $
Mark Goldstone
0.2726 %
3,501 0.2726 % 28 533 $
UBS Securities LLC
0.0913 %
1,172 0.0913 % 9 552 $
Tower Research Capital LLC
0.0777 %
998 0.0777 % 8 134 $
Craig Sheehan
0.0519 %
666 0.0519 % 5 428 $

Company contact information

Guardion Health Sciences, Inc.

2925 Richmond Avenue Suite 1200

77098, Houston

+800 873 5141

http://www.guardionhealth.com
address Guardion Health Sciences, Inc.(GHSI)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
GUARDION HEALTH SCIENCES, INC. Stock Guardion Health Sciences, Inc.
+88.01% 12.26M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+42.69% 750B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+34.11% 606B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.87% 356B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.74% 326B
ABBVIE INC. Stock AbbVie Inc.
+6.76% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.08% 246B
ROCHE HOLDING AG Stock Roche Holding AG
-3.44% 213B
NOVARTIS AG Stock Novartis AG
+11.35% 213B
PFIZER, INC. Stock Pfizer, Inc.
+2.64% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. GHSI Stock
  4. Company Guardion Health Sciences, Inc.